Your browser doesn't support javascript.
loading
Outcomes of Serum Food-Specific Immunoglobulin G 4 to Guide Elimination Diet in Patients With Eosinophilic Esophagitis.
Lim, Amanda Huoy Wen; Ngoi, Benjamin; Perkins, Griffith B; Wong, Stephanie; Whitelock, Gail; Hurtado, Plinio; Ruszkiewicz, Andrew; Le, Thanh-Thao Adriana; Hissaria, Pravin; Nguyen, Nam Quoc.
Afiliação
  • Lim AHW; Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia.
  • Ngoi B; Adelaide Medical School, University of Adelaide, Adelaide, Australia.
  • Perkins GB; Adelaide Medical School, University of Adelaide, Adelaide, Australia.
  • Wong S; Adelaide Medical School, University of Adelaide, Adelaide, Australia.
  • Whitelock G; Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.
  • Hurtado P; Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia.
  • Ruszkiewicz A; Adelaide Medical School, University of Adelaide, Adelaide, Australia.
  • Le TA; Nutrition and Dietetics, Royal Adelaide Hospital, Adelaide, Australia.
  • Hissaria P; Adelaide Medical School, University of Adelaide, Adelaide, Australia.
  • Nguyen NQ; Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.
Am J Gastroenterol ; 119(6): 1066-1073, 2024 06 01.
Article em En | MEDLINE | ID: mdl-38299582
ABSTRACT

INTRODUCTION:

Eosinophilic esophagitis (EoE) is associated with atopy; however, recent studies have identified an association with food-specific immunoglobulin G 4 (FS-IgG 4 ) rather than immunoglobulin E antibodies. This study aimed to evaluate the role of serum FS-IgG 4 in guiding an elimination diet and its outcomes.

METHODS:

Patients with and without EoE were enrolled in a prospective, controlled, single tertiary center trial. Serum FS-IgG 4 titers, esophageal eosinophil counts, and dysphagia symptom questionnaire scores were assessed, and participants with elevated FS-IgG 4 (ImmunoCAP, cutoff of 10 mgA/L) commenced 6-week targeted elimination diet. Repeat serum FS-IgG 4 and endoscopic and histologic examination were performed at 6-week follow-up.

RESULTS:

Twenty-two patients with active EoE and 13 controls were recruited. Serum FS-IgG 4 to milk, wheat, soy, eggs, and nuts was significantly higher in EoE ( P = 0.0002, P = 0.002, P = 0.003, P = 0.012, and P < 0.001, respectively). Elevated serum FS-IgG 4 to 1 or more food groups (median 2) was identified in 21/22 (95.4%) patients with EoE; 20/21 underwent 6-week dietary elimination. Median reductions in dysphagia symptom questionnaire score and EoE endoscopic reference score after elimination were 8 ( P = 0.0007) and 1 ( P = 0.002), respectively. Nine (45%) patients had histological remission (<15 eosinophils per high-power field). Fall in median esophageal eosinophil count was not statistically significant (50 vs 23; P = 0.068). Serum FS-IgG 4 did not decline by 6-week follow-up.

DISCUSSION:

Serum FS-IgG 4 to milk, wheat, soy, egg, and nuts was present at higher levels in EoE, with targeted elimination resulting in 45% histologic remission rate. Serum FS-IgG 4 has potential as a noninvasive biomarker in EoE. When successful, FS-IgG 4 -led elimination diet can negate need for medications and be viewed more favorably by patients because of its smaller endoscopic burden compared with empirical elimination diets.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Esofagite Eosinofílica Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Esofagite Eosinofílica Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article